News
ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia: Culver City, Calif Thursday, April 17, 2025, 15:00 Hrs [IST] ...
B. Braun introduces Ezcover Probe Cover Set for improved ultrasound safety in peripheral nerve block procedures: Bethlehem, Pennsylvania Thursday, April 17, 2025, 14:00 Hrs [IST] ...
Scipher Medicine inks partnership with Kythera Labs to unlock new insights into autoimmune disease-specific treatment: Waltham, Massachusetts Thursday, April 17, 2025, 17:00 Hrs [ ...
LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform: Dublin Thursday, April 17, 2025, 16:00 Hrs [IST] LUMA Vision Ltd, an innovative leader in ...
Meribel Pharma Solutions launches network across Europe to elevate pharma services to new heights: United Kingdom Thursday, April 17, 2025, 18:00 Hrs [IST] UK headquartered Meribe ...
Durham, North Carolina Thursday, April 17, 2025, 12:00 Hrs [IST] ...
Belhaven Biopharma announces promising study results from its dose confirmational clinical trial of Nasdepi: Raleigh, North Carolina Thursday, April 17, 2025, 13:00 Hrs [IST] Belh ...
Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre: Our Bureau, Mumbai Thursday, April 17, 2025, 15:45 ...
Abbott in collaboration with IQVIA highlights that 44% of people have been living with vertigo for more than a year, experiencing episodes once a week. Many mistake vertigo for low blood sugar, low ...
Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...
Peethaambaran Kunnathoor, Chennai Thursday, April 17, 2025, 08:00 Hrs [IST] ...
The Government of NCT of Delhi has announced the appointment of 17 new drug inspectors through gazette notification, pending the notification of eight inspectors out of the 25 newly recruited. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results